Priority Date: 30.03.07 (US 20070909232P)

ANTIBODIES WITH DECREASED DEAMIDATION PROFILES

  • Application ID: EP08744324
  • Status: The application is deemed to be withdrawn

Applicant

Technology company logo small
Technology Company

Attorneys

no operation time available
1 office
Technology Company
no operation time available
1 office
Technology Company
no operation time available
1 office
Technology Company
no operation time available
4 offices
Technology Company

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). AstraZeneca PLC and MedImmune Limited are specialized in the combination A61 and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Sperling Fischer & Heyner, Zacco, Lederer Keller Patentanwälte Partnerschaft mbB and 182 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 30.03.2007 - Priority Date (US 20070909232P)
  • 09.10.2008 - Publication A2 (WO2008121616)
  • 17.06.2009 - Publication A2 (EP2068923)

IPC Classification